Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Japanese researchers describe amidine compounds for eating disorders

Jan. 29, 1999

Nippon Soda discloses new series of inhibitors of cholesterol biosynthesis

Jan. 29, 1999

Another lipid-lowering statin now on the market in Argentina

Jan. 28, 1999

SB patents new cathepsin K inhibitors

Jan. 28, 1999

Widely used herbal antiobesity agent tested in randomized, controlled trial

Jan. 27, 1999

Another market introduction for Lilly's SERM

Jan. 27, 1999

Livial not available in Germany for osteoporosis prevention

Jan. 27, 1999

Potent ACAT inhibitors for lipid disorders from Sankyo

Jan. 27, 1999

Amylin reports additional data from long-term pramlintide studies

Jan. 27, 1999

Japanese authorities approve Viagra

Jan. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...